Certara Investor Day Presentation Deck

CODEX for model-based meta-analysis (MBMA) CODEX Databases cover more than 55 therapeutic areas and 10,000+ studies Influences critical decisions in drug development Used by 9 out of the top 15 global biopharmaceutical companies ● Evidence Synthesis Public Data Optimize dose and dose regimen for a compund Optimize trial design Facilitate early go/no go decisions Perform portfolio profitization and due diligence in support of in/out licensing Show marketing viability and determine market strategy Proprietary Data 66 CERTARA

View entire presentation